The state of Maryland is the global epicenter of vaccine research and development. This has never been more evident than right now as scores of Maryland companies have risen to the global challenge of developing the first approved vaccine for SARS-CoV-2.
Top Seven Biotech Stock Gains in 2020 Linked to COVID-19
Novovax announced that Silvia Taylor, MBA, has joined the company as SVP, Investor Relations, and Corporate Affairs GAITHERSBURG, Md., June 17, 2020 (GLOBE NEWSWIRE) — Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing [….]
Novavax Appoints Biotechnology Veteran David Mott to Board of Directors GAITHERSBURG, Md., June 16, 2020 (GLOBE NEWSWIRE) — Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today [….]
COVID-19 Vaccine Progress from 14 BioHealth Capital Region Companies
In Conversation: Sean Kirk, Emergent BioSolutions Following up on the recent article Two Maryland Biotechs Partner to Bring Coronavirus/COVID-19 Vaccine Candidate into Clinical Trials, BioBuzz had the opportunity to speak [….]
Altimmune Becomes The Second Maryland-Based Biotech Advance Potential Coronavirus/COVID-19 Vaccine As the coronavirus COVID-19 continues to spread across the U.S. — there are currently 150 confirmed cases with 11 total [….]
What’s Behind Novavax’s Coronavirus/COVID-19 Vaccine Development Program The BioHealth Capital Region (BHCR) has a long history of leading the fight against new, frightening diseases, like Ebola and the novel Coronavirus [….]
U.S. Coronavirus Response Could Include These BioHealth Capital Region Organizations The streets of Wuhan, China — the epicenter of the coronavirus outbreak — are empty and quiet except for the [….]
Novavax Signs Strategic Partnership with Catalent’s Paragon BioServices, Secures Company Future and 100’s of Jobs June 27, 2019 Montgomery County Maryland’s Novavax has had a rocky road to say the [….]
